Bruce A. Cohen

Directeur Général chez Statim Pharmaceuticals, Inc.

Profil

Bruce A. Cohen was the founder and had founded VitaPath Genetics, Inc. in 2009, where he held the title of President & Chief Executive Officer.
He is currently the Chief Executive Officer at Statim Pharmaceuticals, Inc. since 2018, a Director at Iconic Therapeutics, Inc., and an Independent Director at Cerca Insights Sdn.
Bhd.
since 2012.
Mr. Cohen has held former positions as President & Chief Executive Officer at Cellerant Therapeutics, Inc., Acacia Biosciences, Inc., and Bionano Genomics, Inc. He was also the Chief Executive Officer at PrIME Biologics Pte Ltd. from 2017 to 2019, Chief Executive Officer at Baysient LLC, Chairman & Treasurer at Viropro, Inc. from 2014 to 2018, Chairman at Xagenic, Inc. from 2012 to 2013, and Director at Chrono Therapeutics, Inc. He served as a Director at Rapid Micro Biosystems, Inc. from 2018 to 2021.
Additionally, he held positions at Baxter International, Inc. as a Planning Analyst, SEQUUS Pharmaceuticals, Inc. as Vice President-Business Unit Management, Genesoft Pharmaceuticals, Inc. as Chief Financial Officer, and Vitel International Holding Co., Inc. as President & Chief Operating Officer.
Mr. Cohen's education includes a graduate degree from Tufts University in 1980, an undergraduate degree from Tufts University in 1975, and an MBA from Harvard Business School in 1982.

Postes actifs de Bruce A. Cohen

Sociétés	Poste	Début
Cerca Insights Sdn. Bhd.	Directeur/Membre du Conseil	29/03/2010
Iconic Therapeutics, Inc.	Directeur/Membre du Conseil	-
Statim Pharmaceuticals, Inc.	Directeur Général	01/11/2018

Anciens postes connus de Bruce A. Cohen

Sociétés	Poste	Fin
RAPID MICRO BIOSYSTEMS, INC.	Directeur/Membre du Conseil	01/01/2021
PrIME Biologics Pte Ltd.	Directeur Général	01/03/2019
Baysient LLC	Directeur Général	01/01/2019
VIROPRO INC.	Président	01/07/2018
Chrono Therapeutics, Inc.	Directeur/Membre du Conseil	-